CervoMed Inc. (CRVO)
NASDAQ: CRVO · Real-Time Price · USD
6.60
-0.04 (-0.60%)
Jan 22, 2026, 2:47 PM EST - Market open
CervoMed Market Cap
CervoMed has a market cap or net worth of $61.07 million as of January 22, 2026. Its market cap has increased by 217.55% in one year.
Market Cap
61.07M
Enterprise Value
34.14M
1-Year Change
217.55%
Ranking
Category
Stock Price
$6.60
Market Cap Chart
Since August 17, 2023, CervoMed's market cap has increased from $43.26M to $61.07M, an increase of 41.16%. That is a compound annual growth rate of 15.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 61.44M | -15.95% |
| Dec 31, 2025 | 73.10M | 278.47% |
| Dec 31, 2024 | 19.31M | -55.39% |
| Dec 29, 2023 | 43.30M | 0.08% |
| Aug 17, 2023 | 43.26M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tevogen Bio Holdings | 67.27M |
| NRx Pharmaceuticals | 66.91M |
| Acrivon Therapeutics | 65.95M |
| TScan Therapeutics | 64.69M |
| ImmuCell | 61.51M |
| Metagenomi Therapeutics | 61.20M |
| Alterity Therapeutics | 58.84M |
| MiNK Therapeutics | 57.64M |